The United States leads in the Global R&D Budget for Health and Medical Sciences with 26.58% of Total GBARD, although it saw a slight decline of 1.14% in 2023. Taiwan and the Netherlands follow, showcasing slight variations with Taiwan growing by 2.05% and the Netherlands dipping by 0.91%. Notable growth performers include Norway at 7.89%, France at 4.72%, and Poland at 5.15%. Iceland reported a dramatic surge of 56.8%, which appears anomalous. Conversely, significant reductions were observed in Estonia (-13.16%) and Lithuania (-20.57%).
Future trends to watch for include:
- Continued strong investments by leading countries like the U.S., Taiwan, and the Netherlands.
- Potential for emerging growth in nations like Norway, France, and Poland.
- Monitoring Iceland for stability post its dramatic increase, and scrutinizing nations with significant declines.
Top countries in R&D Budget for Health and Medical Sciences by Country
| # | 10 Countries | Percent of Total GBARD | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 26.58 | 2023 | -2.24% | -1.14% | View data |
| 2 | 2 Taiwan | 25.25 | 2023 | +1.56% | +2.05% | View data |
| 3 | 3 Netherlands | 24.78 | 2023 | -9.06% | -0.91% | View data |
| 4 | 4 Malta | 24.19 | 2023 | +6.75% | +1.81% | View data |
| 5 | 5 Sweden | 22.97 | 2023 | -3.74% | -3.67% | View data |
| 6 | 6 Norway | 22.83 | 2023 | +5.14% | +7.89% | View data |
| 7 | 7 Australia | 22.03 | 2023 | +1.72% | +3.96% | View data |
| 8 | 8 United Kingdom | 21.72 | 2023 | +1.53% | +0.15% | View data |
| 9 | 9 Spain | 20.4 | 2023 | +2.21% | -0.097% | View data |
| 10 | 10 Luxembourg | 19.07 | 2023 | -0.45% | +3.22% | View data |
